BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 27472323)

  • 1. Acute Generalized Exanthematous Pustulosis: Pathogenesis, Genetic Background, Clinical Variants and Therapy.
    Feldmeyer L; Heidemeyer K; Yawalkar N
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27472323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute generalized exanthematous pustulosis (AGEP): A review and update.
    Szatkowski J; Schwartz RA
    J Am Acad Dermatol; 2015 Nov; 73(5):843-8. PubMed ID: 26354880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Culprit Drugs Induce Specific IL-36 Overexpression in Acute Generalized Exanthematous Pustulosis.
    Meier-Schiesser B; Feldmeyer L; Jankovic D; Mellett M; Satoh TK; Yerly D; Navarini A; Abe R; Yawalkar N; Chung WH; French LE; Contassot E
    J Invest Dermatol; 2019 Apr; 139(4):848-858. PubMed ID: 30395846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore.
    Lee HY; Chou D; Pang SM; Thirumoorthy T
    Int J Dermatol; 2010 May; 49(5):507-12. PubMed ID: 20534083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Generalized Exanthematous Pustulosis: Clinical Characteristics, Pathogenesis, and Management.
    Stadler PC; Oschmann A; Kerl-French K; Maul JT; Oppel EM; Meier-Schiesser B; French LE
    Dermatology; 2023; 239(3):328-333. PubMed ID: 36702114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute generalised exanthematous pustulosis.
    Fernando SL
    Australas J Dermatol; 2012 May; 53(2):87-92. PubMed ID: 22571555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation and management of atypical and recalcitrant acute generalized exanthematous pustulosis.
    Hadavand MA; Kaffenberger B; Cartron AM; Trinidad JCL
    J Am Acad Dermatol; 2022 Sep; 87(3):632-639. PubMed ID: 32926975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute localized exanthematous pustulosis: Clinical features, pathophysiology, and therapy.
    Safa I; Ines L; Noureddine L; Meriem J; Manel N; Belhajali H; Faten Z; Zili J
    Dermatol Ther; 2021 Sep; 34(5):e15087. PubMed ID: 34351040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute generalized exanthematous pustulosis associated with terbinafine: a case report.
    Turan H; Acer E; Erdem H; Uslu E; Aliagaoglu C
    Cutan Ocul Toxicol; 2013 Oct; 32(4):325-6. PubMed ID: 23432048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Generalized Exanthematous Pustulosis: Clinical Features, Differential Diagnosis, and Management.
    Parisi R; Shah H; Navarini AA; Muehleisen B; Ziv M; Shear NH; Dodiuk-Gad RP
    Am J Clin Dermatol; 2023 Jul; 24(4):557-575. PubMed ID: 37156992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute generalized exanthematous pustulosis associated with Mycoplasma pneumoniae infection: a case report].
    Navarrete-Dechent C; Curi-Tuma M; Moll-Manzur C; Dossi MT; Manríquez JJ; González S; Fich F
    Rev Chilena Infectol; 2016 Feb; 33(1):66-70. PubMed ID: 26965881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pustular Psoriasis and Acute Generalized Exanthematous Pustulosis.
    Sussman M; Napodano A; Huang S; Are A; Hsu S; Motaparthi K
    Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Amoxicillin-Induced Acute Generalized Exanthematous Pustulosis Presenting as Septic Shock.
    McDonald KA; Pierscianowski TA
    J Cutan Med Surg; 2017; 21(4):351-355. PubMed ID: 28358593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute generalized exanthematous pustulosis].
    Comstedt LR; Gregersen JH; Bygum A
    Ugeskr Laeger; 2010 Feb; 172(8):628-9. PubMed ID: 20184822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute generalized exanthematous pustulosis secondary to levetiracetam and valproic acid use.
    Levy ZD; Slowey M; Schulder M
    Am J Emerg Med; 2017 Jul; 35(7):1036.e1-1036.e2. PubMed ID: 28189379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case of Acute Generalized Exanthematous Pustulosis by Cefixime with Oral Mucosal Involvement.
    Namoju R; Ismail M; Golla VK; Bamini T; Akarapu TL; Baloju D
    Curr Drug Saf; 2020; 15(3):236-239. PubMed ID: 32729426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute generalized exanthematous pustulosis and polyarthritis associated with a novel CARD14 mutation.
    Podlipnik S; Castellanos-Moreira R; Florez-Enrich H; Arostegui JI; Mascaró JM
    Australas J Dermatol; 2018 Feb; 59(1):e70-e73. PubMed ID: 28776328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute generalized exanthematous pustulosis: atypical presentations and outcomes.
    Kostopoulos TC; Krishna SM; Brinster NK; Ortega-Loayza AG
    J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):209-214. PubMed ID: 25201706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: first case report in Canada and review of the literature.
    Bailey K; McKee D; Wismer J; Shear N
    J Cutan Med Surg; 2013; 17(6):414-8. PubMed ID: 24138979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell involvement in drug-induced acute generalized exanthematous pustulosis.
    Britschgi M; Steiner UC; Schmid S; Depta JP; Senti G; Bircher A; Burkhart C; Yawalkar N; Pichler WJ
    J Clin Invest; 2001 Jun; 107(11):1433-41. PubMed ID: 11390425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.